Keyphrases
Asthma
75%
Severe Asthma
61%
Airway Hyperresponsiveness
25%
Fractional Exhaled Nitric Oxide (FeNO)
19%
Mannitol
15%
Asthma Patients
13%
Asthma Control
12%
Lung Function
11%
Airway
11%
Asthmatic
10%
Oral Corticosteroids
10%
Forced Expiratory Volume in 1 Second (FEV1)
9%
Eosinophilic Inflammation
9%
Denmark
8%
Randomized Controlled Trial
7%
Bronchial Epithelial Cells
7%
Asthma Diagnosis
7%
Acute Exacerbation of COPD (AECOPD)
7%
Type 2 Inflammation
7%
Eosinophils
6%
Adult Patients
6%
Asthma Research
6%
Comorbidity
6%
Biologic Therapy
6%
Airway Inflammation
6%
Asthma Management
6%
Clinical Characteristics
6%
Inhaled Corticosteroids
6%
Exhaled Nitric Oxide
5%
Interleukin-33 (IL-33)
5%
Asthma Exacerbation
5%
Induced Sputum
5%
Sputum
5%
Mast Cells
5%
Asthma Treatment
5%
Exacerbation Rate
5%
Inuit
5%
Tezepelumab
5%
Immunology and Microbiology
Asthma
100%
Severe Asthma
47%
Respiratory Tract Allergy
21%
Exhaled Nitric Oxide
17%
Biological Product
15%
Sputum
14%
Eosinophil Granulocyte
10%
Prevalence
9%
Mast Cell
7%
Comorbidity
6%
Interleukin 5
6%
Asthma Exacerbation
5%
Sensitization
5%
Allergic Asthma
5%
Medicine and Dentistry
Asthma
51%
Severe Asthma
36%
Biological Product
15%
Eosinophilic
11%
Respiratory Tract Allergy
11%
Symptom
10%
Mannitol
9%
Chronic Obstructive Pulmonary Disease
8%
Nitric Oxide
8%
Biological Marker
7%
Respiratory Tract Inflammation
7%
Biological Therapy
7%
Patient with Asthma
7%
Eosinophil
6%
Randomized Controlled Trial
6%
Disease
6%
